We are live on ! Find out more
MDCO

Medicines Co
MDCO

Delisted

MDCO was delisted on the 3rd of January, 2020.

Back to rankings

182 hedge funds and large institutions have $2.6B invested in Medicines Co in 2013 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 64 increasing their positions, 66 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 21

29% more call options, than puts

Call options by funds: $11.1M | Put options by funds: $8.59M

6% more capital invested

Capital invested by funds: $2.46B → $2.6B (+$148M)

6% more funds holding

Funds holding: 172 → 182 (+10)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

3% less repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 66

Holders
182
Holders Change
+10
Holders Change %
+5.81%
% of All Funds
5.28%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
32
Increased
64
Reduced
66
Closed
21
Calls
$11.1M
Puts
$8.59M
Net Calls
+$2.52M
Net Calls Change
-$10.6M

Top Buyers

Rank Fund Capital Flow
1
FCM
Frontier Capital Management
Massachusetts
+$32.2M
2
BM
Bridger Management
New York
+$22.5M
3
Neuberger Berman Group
Neuberger Berman Group
New York
+$16.2M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$14.9M
5
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$11.2M

Top Sellers

Rank Fund Capital Flow
1
PC
PointState Capital
New York
-$51.8M
2
ZDA
Zweig-DiMenna Associates
New York
-$21.6M
3
Citadel Advisors
Citadel Advisors
Florida
-$12.7M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$11.1M
5
PHS
PFM Health Sciences
California
-$8.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIG
101
American International Group
New York
$1.93M +$188K +5,264 +12%
SFM
102
Soros Fund Management
New York
$1.93M -$7.15M -200,000 -80%
CCM
103
Catapult Capital Management
New York
$1.93M +$1.79M +50,000 New
Susquehanna International Group
104
Susquehanna International Group
Pennsylvania
$1.79M -$326K -9,127 -16%
USAA
105
United Services Automobile Association
Texas
$1.76M – – –
SFM
106
Sphera Funds Management
Israel
$1.7M +$1.57M +44,000 New
DCM
107
Dupont Capital Management
Delaware
$1.67M +$1.03M +28,757 +197%
SIM
108
Spark Investment Management
New York
$1.61M – – –
HHC
109
Hutchin Hill Capital
New York
$1.5M +$1.39M +38,800 New
FQ
110
First Quadrant
California
$1.42M -$114K -3,200 -8%
DekaBank Deutsche Girozentrale
111
DekaBank Deutsche Girozentrale
Germany
$1.37M +$25K +700 +2%
CAM
112
Capstone Asset Management
Texas
$1.31M -$132K -3,681 -10%
ProShare Advisors
113
ProShare Advisors
Maryland
$1.29M -$1.07M -29,820 -47%
RSCM
114
Rock Springs Capital Management
Maryland
$1.25M +$1.16M +32,500 New
AQR Capital Management
115
AQR Capital Management
Connecticut
$1.22M +$479K +13,400 +74%
JGC
116
J. Goldman & Co
New York
$1.16M -$8.36M -233,750 -89%
HCMT
117
Highland Capital Management (Texas)
Texas
$1.16M +$1.07M +30,000 New
LSERS
118
Louisiana State Employees Retirement System
Louisiana
$1.14M +$1.05M +29,500 New
CBOA
119
Commonwealth Bank of Australia
Australia
$1.11M -$82.2K -2,300 -7%
MAA
120
Managed Account Advisors
New Jersey
$1.11M +$85.7K +2,396 +9%
U
121
UBS
Switzerland
$1.09M -$8.22K -230 -0.8%
Citigroup
122
Citigroup
New York
$1.01M +$505K +14,117 +116%
BHTS
123
Bar Harbor Trust Services
Maine
$1M +$10.7K +300 +1%
MAM
124
Martingale Asset Management
Massachusetts
$997K +$168K +4,696 +22%
Nomura Holdings
125
Nomura Holdings
Japan
$969K -$496K -13,883 -36%
3 4
5
6 7

MDCO Hedge Fund Activity: Q4 2013 in Review

182 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q4 2013, worth a combined $2.6B — up 6% from $2.46B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new MDCO positions and 21 closed out — a net gain of 11 holders — while 64 added to existing stakes and 66 trimmed.

The largest buyer was Frontier Capital Management, adding an estimated $32.2M. The largest seller was PointState Capital, cutting an estimated $51.8M.

  • 182 institutional investors held Medicines Co (MDCO) as of Q4 2013, up from 172 in Q3 2013.
  • Funds reported $2.6B of Medicines Co stock for Q4 2013, up 6% quarter-over-quarter.
  • 32 funds opened new Medicines Co positions in Q4 2013 and 21 closed out, a net change of +11 holders.
  • The largest Medicines Co buyer in Q4 2013 was Frontier Capital Management, an estimated $32.2M added.
  • The largest Medicines Co seller in Q4 2013 was PointState Capital, an estimated $51.8M sold.

Based on aggregated 13F filings for Q4 2013.